A study in Japanese and Caucasian subjects with subcutaneous atacicept
Research type
Research Study
Full title
A phase I, double-blind, randomized, placebo-controlled, single-dose, parallel-group trial of subcutaneous atacicept in healthy Japanese and matched Caucasian subjects to assess the safety, tolerability, pharmacokinetics and pharmacodynamics
IRAS ID
137124
Contact name
Arpeat Kaviya
Contact email
Sponsor organisation
Merck KGaA
Eudract number
2013-002703-34
REC name
HSC REC B
REC reference
13/NI/0128
Date of REC Opinion
7 Oct 2013
REC opinion
Further Information Favourable Opinion